These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 10805476)

  • 1. Angiotensin converting enzyme inhibition in non-diabetic nephropathy with non-nephrotic proteinuria.
    Pennesi M; Torre G
    Pediatr Nephrol; 2000 May; 14(5):438. PubMed ID: 10805476
    [No Abstract]   [Full Text] [Related]  

  • 2. [ACE-inhibitors indicated even in non-diabetic nephropathy].
    Internist (Berl); 1996 Oct; 37(10 Suppl Ace-hemmer):1-8. PubMed ID: 9402421
    [No Abstract]   [Full Text] [Related]  

  • 3. [Further evidence for the renoprotective effect of ACE inhibitors: ramipril protects against the progression of chronic renal insufficiency in non-diabetic nephropathy with nephrotic proteinuria].
    Mayr M; Dickenmann MJ
    Schweiz Med Wochenschr; 2000 Apr; 130(13):491. PubMed ID: 10812646
    [No Abstract]   [Full Text] [Related]  

  • 4. Angiotensin-I converting enzyme inhibition: clinical effects in chronic renal disease.
    de Jong PE; Heeg JE; Apperloo AJ; de Zeeuw D
    Am J Kidney Dis; 1991 May; 17(5 Suppl 1):85-8. PubMed ID: 2024682
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker.
    Furumatsu Y; Nagasawa Y; Tomida K; Mikami S; Kaneko T; Okada N; Tsubakihara Y; Imai E; Shoji T
    Hypertens Res; 2008 Jan; 31(1):59-67. PubMed ID: 18360019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal and cardiovascular effects of angiotensin-converting enzyme inhibitor plus angiotensin II receptor antagonist therapy in children with proteinuria.
    Lubrano R; Soscia F; Elli M; Ventriglia F; Raggi C; Travasso E; Scateni S; Di Maio V; Versacci P; Masciangelo R; Romero S
    Pediatrics; 2006 Sep; 118(3):e833-8. PubMed ID: 16923922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive therapy for nondiabetic nephropathy.
    Maschio G
    Am J Kidney Dis; 2000 Apr; 35(4):liv-lvi. PubMed ID: 10809659
    [No Abstract]   [Full Text] [Related]  

  • 8. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive treatment and glomerular size selectivity in hypertensive patients with renal parenchymal disease and proteinuria.
    Shand BI; Lewis JG; Elder PA; Agarwal M
    Clin Nephrol; 2002 Oct; 58(4):321-4. PubMed ID: 12400851
    [No Abstract]   [Full Text] [Related]  

  • 10. [What is the purpose of dual or triple inhibition of the renin-angiotensin-aldosterone system?].
    Legrand D; Krzesinski JM; Scheen AJ
    Rev Med Suisse; 2008 Aug; 4(168):1792-7. PubMed ID: 18814762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of IgA nephropathy with angiotensin converting enzyme inhibitors: design of a prospective randomized multicenter trial.
    Coppo R; Chiesa M; Peruzzi L; Amore A
    J Nephrol; 2001; 14(6):447-52. PubMed ID: 11783600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hemolytic uremic syndrome. Treatment of secondary glomerulopathy].
    Caletti MG; Gallo G
    Medicina (B Aires); 2005; 65(6):528-32. PubMed ID: 16433483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme inhibitors in diabetes: effect on the kidney and on blood pressure.
    Björck S; Aurell M
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S59-63. PubMed ID: 16989067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of proteinuria on cardiovascular risk and response to angiotensin-converting enzyme inhibition after myocardial infarction.
    Jose P; Tomson C; Skali H; Rouleau J; Braunwald E; Arnold JM; Cuddy T; Sussex B; Bernstein V; Pfeffer M; Solomon S
    J Am Coll Cardiol; 2006 Apr; 47(8):1725-7. PubMed ID: 16631015
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of N-acetylcysteine on proteinuria and markers of tubular injury in non-diabetic patients with chronic kidney disease. A placebo-controlled, randomized, open, cross-over study.
    Renke M; Tylicki L; Rutkowski P; Larczyński W; Aleksandrowicz E; Lysiak-Szydłowska W; Rutkowski B
    Kidney Blood Press Res; 2008; 31(6):404-10. PubMed ID: 19092257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose dual blockade of the renin-angiotensin system improves tubular status in non-diabetic proteinuric patients.
    Renke M; Tylicki L; Rutkowski P; Wojnarowski K; Lysiak-Szydlowska W; Rutkowski B
    Scand J Urol Nephrol; 2005; 39(6):511-7. PubMed ID: 16303729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgACE: a placebo-controlled, randomized trial of angiotensin-converting enzyme inhibitors in children and young people with IgA nephropathy and moderate proteinuria.
    Coppo R; Peruzzi L; Amore A; Piccoli A; Cochat P; Stone R; Kirschstein M; Linné T
    J Am Soc Nephrol; 2007 Jun; 18(6):1880-8. PubMed ID: 17513327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maximizing inhibition of the renin-angiotensin system with high doses of converting enzyme inhibitors or angiotensin receptor blockers.
    Berl T
    Nephrol Dial Transplant; 2008 Aug; 23(8):2443-7. PubMed ID: 18467376
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term benefits of the antiproteinuric effect of angiotensin-converting enzyme inhibition in nondiabetic renal disease.
    Gansevoort RT; de Zeeuw D; de Jong PE
    Am J Kidney Dis; 1993 Jul; 22(1):202-6. PubMed ID: 8322784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term effect of angiotensin-converting inhibitors in children with proteinuria].
    Camacho Díaz JA; Giménez Llort A; García García L; Jiménez González R
    An Esp Pediatr; 2001 Sep; 55(3):219-24. PubMed ID: 11676896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.